Payday still applies
Jung will be entitled to a $1 million annual base salary. She'll also be eligible for a discretionary cash bonus based on the board's assessment of her performance and success during the transition period to a new, separate CEO; the target award is equal to 100% of base salary.
She'll continue to participate in Avon's three-year long-term incentive program, with an annual target award equal to 400% of annual base salary after 2012. She'll remain covered by the company's executive retirement and death benefits plans, as well as by the medical, dental, life and disability insurance, 401(k) plan, pension plan, and so forth.
According to the regulatory filing, Jung's potential severance benefits and potential change of control benefits have been "significantly reduced" from those under her previous employment agreement.
Incidentally, Jung's new base salary as executive chairman isn't far off from her annual pay as chairman and CEO (last year, her base salary was $1,375,000).
Parting's sweet sorrow (and sweet payouts)
Earlier this week, Avon shares surged on the plans for a new CEO next year, but it seemed prudent to wait past that initial euphoria to see what kind of consolation prize Jung might get. The golden parachute is always the other side of the story when a CEO leaves the helm, since it represents shareholder money.
Jung's compensation for her stripped-down chairman role isn't as shocking as what transpired at Nabors Industries
Avon's makeover has just begun
Jung's situation seems mixed from the shareholder perspective. As much as it's great to see separate individuals in the chairman and CEO roles, I'd rather see an independent chairman, not a former member of management, and of course, this seems like an awfully expensive way to go about separating those roles. On the other hand, despite the last several years' lackluster results, Jung has served as Avon's CEO since 1999, and is credited with several important changes to the business. Avon shareholders could have experienced a far costlier (and less productive) exit.
Regardless of anything else, though, investors who bid Avon shares up earlier this week were more than a little bit premature. Avon has formidable competition from the likes of Procter & Gamble
What do you think? Is Avon suddenly, magically a fresh investment idea? Let us know in the comments box below, or add Avon Products to My Watchlist to keep track of coming developments.
Alyce Lomax does not own shares of any of the companies mentioned. Motley Fool newsletter services have recommended buying shares of Procter & Gamble. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.